Trending >

Acreage Holdings has an upside of 77 per cent, Beacon says

Valens

US cannabis company Acreage Holdings (Acreage Holdings Stock Quote, Chart CSE:ACRG.U) has opened its first dispensary in Ohio, a state which should have a sizeable medical cannabis market, says Beacon Securities analyst Russell Stanley, who in a research update to clients Thursday interpreted the announcement as a positive for the company.

New York-based Acreage, which has cannabis cultivation, production and retail interests across 19 states, took part in Ohio’s opening day sales as the state ushers in a new medical marijuana industry, starting with just four stores. Acreage’s store in Canton will be run by Greenleaf Apothecaries, with whom Acreage has a management services agreement.

Stanley says there is likely to be limited product availability at the outset but that with a population of 11.7 million, Ohio will be a big market for Acreage.

“We have already included Ohio in our model and valuation (revenue of $14 million in 2019, $28 million in 2020), our forecasts are unchanged. However, we view the news positively as it represents continued execution of the growth strategy, and positions the company as an early mover in what should be a significant medical cannabis market,” says Stanley. (All figures in US dollars.)

“One local media source estimated that as many as 30 per cent of people in the state (i.e., 3.5 million people) could qualify for medical cannabis use, based on the original set of allowable medical conditions. Even achieving an Arizona-like penetration level of 2.6 per cent implies a potential patient base of over 300,000,” he says.

Stanley expects Acreage to generate Adjusted EBITDA in 2019 of $60 million on revenue of $272 million and Adjusted EBITDA in 2020 of $158 million on a top line of $533 million.

The analyst is maintaining his “Buy” rating and $40.00 target price, representing a projected return of 77 per cent at the time of publication.

  •  
  •  
  •  

About The Author /

Jayson MacLean
Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Access Expert Stock Picks for free

CLOSE

Get Stock Picks From The Pros

Sign up for our newsletter to get timely Canadian stock picks from expert financial analysts.